Project ACT14820-Moves-PD

Basic data

Title:
ACT14820-Moves-PD
Duration:
01/05/2017 to 30/04/2022
Abstract / short description:
Multizentrische, randomisierte, doppelblinde, placebokontrollierte Studie zur Beurteilung der Wirksamkeit, Sicherheit, Pharmakokinetik und Pharmakodynamik von GZ/SAR402671 bei Patienten mit Morbus Parkinson im Frühstadium, die eine GBA-Mutation tragen

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychology
Faculty of Science
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Frankfurt am Main, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.